Bellamy's Chinese takeover approved

Bellamy's Australia Ltd (ASX: BAL) shareholders got an early Christmas present today after the FIRB approved its takeover of the China Mengniu Dairy Company Limited (Mengniu). 

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Bellamy's Australia Ltd (ASX: BAL) shareholders got an early Christmas present today after the Foreign Investment Review Board approved its takeover of the China Mengniu Dairy Company Limited (Mengniu). 

The September 16 takeover bid is worth $13.25 per share being a $12.65 per share cash offer plus a 60 cents per share fully franked special dividend to be paid prior to the scheme's implementation. The offer valued Bellamy's at around 30x FY 2019's EBITDA at a 59% premium to the September 13 share price of $8.32.

At the time of the offer more than 10% of Bellamy's outstanding shares were short sold to equal some painful losses for hedge funds betting on the share price falling. 

More generally the takeover demonstrates how the market for Australian infant formula in China remains strong with other businesses like the a2 Milk Company Ltd (ASX: A2M) and Bubs Australia Ltd (ASX: BUB) also posting strong growth in China.

Motley Fool contributor Tom Richardson owns shares of A2 Milk. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

ASX board.
ASX Share Market News

Why the ASX 200 is pushing higher as rate hike fears grow

Tech stocks are leading the market rebound today.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »